Skip to main content
. 2020 May 28;18:214. doi: 10.1186/s12967-020-02370-4

Table 5.

Secondary analysis: PD-L1

PD-L1 density (mm2/mm2) Rituximab
Mean (95% CI)
Controls
Mean (95% CI)
p
Tumor region 0.059 (0.018, 0.099) 0.083 (0.040, 0.127) 0.36
Non-neoplastic region 0.054 (0.004, 0.103) 0.132 (0.056, 0.321) 0.39
Within group difference
 Tumor − non-neoplastic 0.005 (− 0.012, + 0.022) − 0.049 (− 0.248, + 0.151)  0.56

1. Density of tumor for subjects treated with rituximab

2. Density of adjacent normal tissue for subjects treated with rituximab

3. Use one sample t test to get the mean and 95% CI

4. p value is from two sample t-test

For two sample t-test, the Welch (or Satterthwaite) approximation to the degrees of freedom is used

Null hypothesis is no difference

5. (Tumor − normal) is calculated by: column K − column L